The Global Polycystic Ovarian Syndrome Market is segmented on the basis of diagnosis, treatment, and end-user. The polycystic ovarian syndrome Industry, by diagnosis, is categorized into the pelvic examination, transvaginal ultrasound and blood tests.
—
Polycystic Ovarian Syndrome Market Scenario
The Polycystic Ovarian Syndrome Market is expected to witness tremendous growth owing to the rising prevalence of polycystic ovarian syndrome. According to the Centers for Disease Control and Prevention, approximately 5 million women of reproductive age suffer from the polycystic ovarian syndrome.
Polycystic Ovary Syndrome (PCOS) is a medical condition where the women of reproductive age suffer from hormonal disorders. This is due to an increase in levels of male hormones in the body which leads to an irregular menstrual cycle. Women experience symptoms such as irregular menstrual cycle, increase in facial hair growth, acne, thinning hair or hair loss on the scalp, weight gain, darkening of skin and others. Polycystic Ovary Syndrome (PCOS) is caused due to high levels of androgens, excess insulin, low-grade inflammation, cysts in the ovaries, and genetic disorders.
Other key factors such as the growing obesity among women, rising prevalence of diabetes, increasing hormonal disorders in women, change in sedentary lifestyle, socioeconomic factors, growing consumption of unhealthy diet, and others are contributing towards the growth of the market. Diabetes is another risk factor that leads to the development of the polycystic ovarian syndrome. Such factors contribute to polycystic ovarian syndrome among women.
Get Exclusive Sample Copy @ https://www.marketresearchfuture.com/sample_request/6295
However, factors such as side effects associated with drugs such as weight gain, cardiovascular risks, increase insulin resistance, abnormal glucose tolerance, and thromboembolic events are expected to restrict the market growth during the forecast period.
Segmentation
The Global Polycystic Ovarian Syndrome Market is segmented on the basis of diagnosis, treatment, and end-user. The polycystic ovarian syndrome market, by diagnosis, is categorized into pelvic examination, transvaginal ultrasound, and blood tests. Blood tests are further sub-segmented into hormone levels, glucose tolerance, and cholesterol and triglyceride levels. On the basis of treatment, the market is segmented into oral contraceptives, antiandrogens, insulin-sensitizing agents, antidepressant, anti-obesity, and surgery. The surgery category includes ovarian wedge resection and laparoscopic ovarian drilling. On the basis of end-user, the market is segmented into hospitals and clinics, ambulatory surgical centers, diagnostic centers, gynecology centers, feminist health centers and others.
Key Players
Bayer AG, AstraZeneca plc, Abbott, Biocinese, Catalysis, S.L., Crinetics Pharmaceuticals, Inc., Sanofi, Eugonia, EffRx, Inc., Ferring Pharmaceuticals, Inc., Merck KGaA, Bristol-Myer Squibb Company, Neurocrine Biosciences, Inc., Reliance Life Sciences Pvt. Ltd. Pfizer, Inc., Novartis AG, and Shire Plc.
Regional Analysis
The Americas is expected to dominate the Polycystic Ovarian Syndrome Market during the forecast period. The increasing prevalence of polycystic ovarian syndrome drives the market in this region. According to the Centers for Disease Control and Prevention, the Polycystic Ovary Syndrome (PCOS) affects 6 to 12% of the American women of the childbearing age. This is expected to influence the market growth during the forecast period.
Europe (UK, Belgium, France, and Netherlands) is the second largest in the market owing to the increasing prevalence of obesity and growing healthcare expenditure. The increasing research activities for Polycystic Ovary Syndrome (PCOS) are influencing the market growth. EuroSciCon will hold the 5th World Congress on Polycystic Ovarian Disorder in April 2019 in Berlin, Germany to discuss diagnosis and intervention of the polycystic ovarian syndrome.
Asia-Pacific was projected to be the fastest growing region for the global polycystic ovarian syndrome market in 2017. The market is expected to witness growth owing to the rising prevalence of diabetes in women, changing lifestyle, and growing obesity within the female population. The Asian Diabetes Prevention Initiative estimated that by 2030 India and China will have a diabetic patient pool with a total of half billion people. Furthermore, according to the Journal of the American Medical Association in 2013, China had 187.7 million women suffering from prediabetes. This is expected to provide favorable backgrounds for the market to grow.
The Middle East and Africa accounts for the least share due to stringent government policies and low per capita income.
Ask To Experts @ https://www.marketresearchfuture.com/enquiry/6295
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Info:
Name: Market Research Future
Organization: Market Research Future
Address: Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar, Pune – 411028 Maharashtra, India
Phone: +1 646 845 9312
For more information, please visit https://www.marketresearchfuture.com/reports/polycystic-ovarian-syndrome-market-6295
Source: MarketersMedia
Release ID: 394639
